Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical Chemistry and Laboratory Medicine|September 24, 2005
The effect of long-term storage on measured plasma lactate concentrations and prospective lactate results from a multicenter trial of antiretroviral therapyMichael P Dubé, Douglas W Kitch, Robert A Parker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 13, 2006
Predictors of antiretroviral-related hepatotoxicity in the adult AIDS Clinical Trial Group (1989-1999)Julie C Servoss, Douglas W Kitch, Janet W Andersen, et al.
HIV Clinical Trials|February 11, 2009
Simplification of the research diagnosis of HIV-associated sensory neuropathyScott R Evans, David B Clifford, Douglas W Kitch, et al.
The Journal of Antimicrobial Chemotherapy|April 4, 2017
Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224sSamir K Gupta, Eunice Yeh, Douglas W Kitch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2025
The Bounce-Back Effect: What Happens After Cessation of Low-Dose Semaglutide in People with HIVKristine M Erlandson, Douglas W Kitch, Amy Kantor, et al.
Npj Aging|April 21, 2026
Pilot study of epigenetic aging and treatment response to semaglutide in the SLIM LIVER studyMichael J Corley, Alina P S Pang, Douglas W Kitch, et al.
Journal of Virus Eradication|February 26, 2019
Stability of plasma indices of inflammation/coagulation and homeostasis after fatty and non-fatty meals in treated people with HIVDominic Dorazio, Douglas W Kitch, Netanya S Utay, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186John G Gerber, Douglas W Kitch, Carl J Fichtenbaum, et al.
Pageof 2